Is a lower dose of trimethoprim sulfamethoxazole for Pneumocystis jirovecii pneumonia just as effective, but safer?
- DOI
- 10.1016/j.cmi.2026.10.037
- Published
- 2026 Nov 6
- Container
- Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.cmi.2026.10.037,
title = {Is a lower dose of trimethoprim sulfamethoxazole for Pneumocystis jirovecii pneumonia just as effective, but safer?},
author = {McDonald EG and Ezer N and Cheng MP and Sohani ZN and Lee TC},
year = {2026},
journal = {Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases},
doi = {10.1016/j.cmi.2026.10.037},
url = {https://doi.org/10.1016/j.cmi.2026.10.037}
}RIS
TY - JOUR TI - Is a lower dose of trimethoprim sulfamethoxazole for Pneumocystis jirovecii pneumonia just as effective, but safer? AU - McDonald EG AU - Ezer N AU - Cheng MP AU - Sohani ZN AU - Lee TC PY - 2026 JO - Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases DO - 10.1016/j.cmi.2026.10.037 UR - https://doi.org/10.1016/j.cmi.2026.10.037 ER -
APA
EG, M., N, E., MP, C., ZN, S., & TC, L. (2026). Is a lower dose of trimethoprim sulfamethoxazole for Pneumocystis jirovecii pneumonia just as effective, but safer?. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. https://doi.org/10.1016/j.cmi.2026.10.037
Source records
- pubmed · retrieved 2026-11-10T11:32:38.153Z